Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug BHV-1300 tested for Graves' disease safety

NCT ID NCT06980649

Recruiting now Disease control Sponsor: Biohaven Therapeutics Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This early study is testing a new drug called BHV-1300 in 15 people with Graves' disease. The main goal is to see if the drug is safe and to check how it affects certain markers of the disease. This is a phase 1 trial, so it's one of the first steps in testing this treatment in humans.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease endocrine system disorder Graves disease hyperthyroidism thyroid gland disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GRAVES DISEASE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Site-001

    RECRUITING

    Kotara, 2289, Australia

  • Site-002

    RECRUITING

    Torquay, 3228, Australia

  • Site-003

    RECRUITING

    Melbourne, 3128, Australia

  • Site-004

    RECRUITING

    Fitzroy, 3065, Australia

  • Site-006

    RECRUITING

    St Leonards, 2065, Australia

  • Site-008

    RECRUITING

    Parkville, 3050, Australia

  • Site-010

    RECRUITING

    Oaklands Park, 5046, Australia

  • Site-011

    RECRUITING

    Herston, 4029, Australia

  • Site-100

    RECRUITING

    Miami, Florida, 33126, United States

  • Site-101

    RECRUITING

    Houston, Texas, 77095, United States

  • Site-103

    RECRUITING

    South Gate, California, 90280, United States

  • Site-104

    RECRUITING

    Columbus, Georgia, 31904, United States

  • Site-105

    RECRUITING

    Shavano Park, Texas, 78231, United States

  • Site-106

    RECRUITING

    Houston, Texas, 77054, United States

  • Site-107

    RECRUITING

    Memphis, Tennessee, 38119, United States

  • Site-108

    RECRUITING

    Greenville, North Carolina, 27834, United States

  • Site-109

    RECRUITING

    Dallas, Texas, 75246, United States

  • Site-110

    RECRUITING

    Canton, Ohio, 44718, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.